Inhibikase Therapeutics (IKT)
(Delayed Data from NSDQ)
$1.39 USD
+0.05 (3.73%)
Updated Sep 9, 2024 03:59 PM ET
After-Market: $1.39 0.00 (0.00%) 6:20 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.67 | 0.00% |
Earnings Summary
For their last quarter, Inhibikase Therapeutics (IKT) reported earnings of -$0.66 per share, missing the Zacks Consensus Estimate of -$0.58 per share. This reflects a negative earnings surprise of 13.79%. Look out for IKT's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.67 per share, reflecting a year-over-year increase of 22.09%.
Earnings History
Price & Consensus
Zacks News for IKT
New Strong Buy Stocks for February 13th
IKT: What are Zacks experts saying now?
Zacks Private Portfolio Services